Skip to main content
Log in

Lipid Lowering Drugs: What is Their Place in Therapeutics?

  • Practical Therapeutic
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Study Group of Physicians, Newcastle-Upon-Tyne: Trial of clofibrate in treatment of ischaemic heart disease. British Medical Journal 2: 767–775 (1971).

    Google Scholar 

  2. Scottish Society of Physicians: Ischaemic heart disease: A secondary prevention trial using clofibrate. British Medical Journal 2: 775–784 (1971).

    Article  Google Scholar 

  3. Krasno, L.R. and Kidera, G.J.: Clofibrate in coronary heart disease: Effect on morbidity and mortality. Journal of American Medical Association 219: 845–851 (1972).

    Article  CAS  Google Scholar 

  4. The Coronary Drug Project Research Group: Clofibrate and niacin in coronary heart disease. Journal of American Medical Association 231: 360–381 (1975).

    Article  Google Scholar 

  5. Carlson, L.A.; Danielson, M.; Ekberg, I. et al.: Reduction of myocardial re-infarction by the combined treatment with clofibrate and nicotinic acid. Atherosclerosis 28: 81–86 ( 1977).

    Article  PubMed  CAS  Google Scholar 

  6. Door, A.E.; Gundersen, K.; Schneider, J.C. et al.: Colestipol hydrochloride in hypercholesterolemic patients. Effect on serum cholesterol and mortality. Journal of Chronic Diseases 31: 5–14 (1978).

    Article  Google Scholar 

  7. Committee of Principal Investigators: A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. British Heart Journal 40: 1069–1118 (1978).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simons, L. Lipid Lowering Drugs: What is Their Place in Therapeutics?. Drugs 17, 501–506 (1979). https://doi.org/10.2165/00003495-197917060-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197917060-00006

Keywords

Navigation